PMID: 9521626May 16, 1998

Selective elevation of glutathione levels in target tissues with L-2-oxothiazolidine-4-carboxylate (OTC) protects against hyperoxia-induced lung damage in protein-energy malnourished rats: implications for a new treatment strategy

The Journal of Nutrition
M A LevyT M Bray


It has become recognized that enhancing the antioxidant defense system during the early phase of rehabilitation is important to the survival of wasting protein-energy malnourished (PEM) patients. In this study, we compared the efficacy of dietary protein replenishment and supplementation with L-2-oxothiazolidine-4-carboxylate (OTC, 3.5 mg/d), a cysteine precursor, to protect against hyperoxia-induced lung damage in PEM rats. The PEM rats were produced by feeding weanling rats a protein-deficient diet (0.5% protein) for 14 d. PEM rats were then divided in three dietary treatment groups, 0.5% protein (-Pr), 0.5% protein plus the OTC supplement (+OTC), or 15% protein (+Pr) during 4 d of either hyperoxia (85% O2) or air exposure. Increased lung-to-body weight ratios, indicative of oxidative tissue damage, were observed following exposure to hyperoxia in -Pr and +Pr rats, but not in +OTC rats, even though the OTC supplement and the 15% protein diet contained a comparable amount of cysteine. Tissue reduced glutathione (GSH) status, GSH-dependent enzyme activity and antioxidant defense enzyme activities were monitored in the lung, liver and blood during 4 d of hyperoxia exposure. OTC supplementation enhanced GSH levels significantly i...Continue Reading


Aug 19, 1976·The New England Journal of Medicine·E Beutler
Jul 1, 1978·Journal of Biochemistry·N KohashiI Ueda
Jan 1, 1978·Methods in Enzymology·J D CrapoI Fridovich
Sep 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C G TaylorT M Bray
Nov 1, 1990·Reviews of Infectious Diseases·T E TupasiM G Lucero
Feb 1, 1987·The Proceedings of the Nutrition Society·M H Golden, D Ramdath
Jul 1, 1970·Physiological Reviews·A E HarperR M Wohlhueter
Jan 1, 1983·Annual Review of Biochemistry·A Meister, M E Anderson
Jun 15, 1994·Biochemical Pharmacology·T M Bray, C G Taylor
Jan 1, 1997·Free Radical Biology & Medicine·C G TaylorT M Bray
Feb 1, 1983·Biological Trace Element Research·J R Prohaska, D E Gutsch


May 10, 2000·The Journal of Nutrition·P J FrakerT L Vollmer
Nov 28, 2006·International Journal of Food Sciences and Nutrition·James B LothianLarry C Lands
Mar 11, 2000·Current Opinion in Clinical Nutrition and Metabolic Care·J Wernerman, F Hammarqvist
Jul 2, 2003·Neurotoxicity Research·P G Paterson, B H Juurlink
Jul 25, 2007·Biological Trace Element Research·Olusegun Lateef Adebayo, Gbenga Adebola Adenuga

Related Concepts

2-oxothiazolidine-4-carboxylic acid, (S)-isomer
Dietary Proteins
Reduced Glutathione
Rats, Wistar

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.